Company · CIK 1479290
Revance Therapeutics, Inc.
| CIK | 1479290 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | TN |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2014-03-28 |
Offerings
8 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-275548 | 2023-11-14 | 2024-03-05 | 3 | |
| 333-250998 | 2020-11-27 | 2022-09-14 | 4 | |
| 333-221911 | 2017-12-05 | 2019-12-04 | 8 | |
| 333-210001 | 2016-03-07 | 2016-03-25 | 3 | |
| 333-202494 | 2015-03-04 | 2015-11-04 | 5 | |
| 333-207469 | 2015-10-16 | 2015-11-02 | 2 | |
| 333-196582 | 2014-06-06 | 2014-06-19 | 5 | |
| 333-193154 | 2013-12-31 | 2014-02-06 | 5 |
Filings
37| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-03-05 | 424B5Shelf takedown | 333-275548 | 0001193125-24-059381 |
| 2024-03-04 | 424B5Shelf takedown | 333-275548 | 0001193125-24-056758 |
| 2023-11-14 | S-3ASRShelf registered | 333-275548 | 0001193125-23-277129 |
| 2022-09-14 | 424B5Shelf takedown | 333-250998 | 0001193125-22-243983 |
| 2022-09-12 | 424B5Shelf takedown | 333-250998 | 0001193125-22-242867 |
| 2022-05-10 | 424B5Shelf takedown | 333-250998 | 0001193125-22-146394 |
| 2020-11-27 | S-3ASRShelf registered | 333-250998 | 0001193125-20-304517 |
| 2020-06-24 | EFFECTDeclared effective | 333-239059 | 9999999995-20-001527 |
| 2019-12-04 | 424B5Shelf takedown | 333-221911 | 0001193125-19-306287 |
| 2019-12-03 | 424B5Shelf takedown | 333-221911 | 0001193125-19-305271 |
| 2019-01-17 | 424B5Shelf takedown | 333-221911 | 0001193125-19-010941 |
| 2019-01-15 | 424B5Shelf takedown | 333-221911 | 0001193125-19-009773 |
| 2018-03-13 | 424B5Shelf takedown | 333-221911 | 0001193125-18-080738 |
| 2017-12-07 | 424B5Shelf takedown | 333-221911 | 0001193125-17-363396 |
| 2017-12-05 | 424B5Shelf takedown | 333-221911 | 0001193125-17-361794 |
| 2017-12-05 | S-3ASRShelf registered | 333-221911 | 0001193125-17-361654 |
| 2016-03-25 | EFFECTDeclared effective | 333-210001 | 9999999995-16-004046 |
| 2016-03-25 | 424B5Shelf takedown | 333-210001 | 0001193125-16-518171 |
| 2016-03-07 | S-3Shelf registered | 333-210001 | 0001193125-16-495445 |
| 2015-11-04 | 424B5Shelf takedown | 333-202494 | 0001193125-15-365121 |
| 2015-11-02 | EFFECTDeclared effective | 333-207469 | 9999999995-15-002935 |
| 2015-11-02 | 424B5Shelf takedown | 333-202494 | 0001193125-15-361244 |
| 2015-10-16 | S-3Shelf registered | 333-207469 | 0001479290-15-000004 |
| 2015-03-19 | 424B5Shelf takedown | 333-202494 | 0001628280-15-001861 |
| 2015-03-18 | EFFECTDeclared effective | 333-202494 | 9999999995-15-000633 |
| 2015-03-04 | S-3Shelf registered | 333-202494 | 0001628280-15-001464 |
| 2014-06-19 | 424B4Final prospectus | 333-196582 | 0001193125-14-241675 |
| 2014-06-18 | EFFECTDeclared effective | 333-196582 | 9999999995-14-001822 |
| 2014-06-18 | S-1/AAmendment | 333-196582 | 0001193125-14-240667 |
| 2014-06-16 | S-1/AAmendment | 333-196582 | 0001193125-14-237646 |
| 2014-06-06 | S-1Registration filed | 333-196582 | 0001193125-14-228901 |
| 2014-02-06 | 424B4Final prospectus | 333-193154 | 0001193125-14-037802 |
| 2014-02-05 | EFFECTDeclared effective | 333-193154 | 9999999995-14-000330 |
| 2014-02-03 | S-1/AAmendment | 333-193154 | 0001193125-14-033118 |
| 2014-01-27 | S-1/AAmendment | 333-193154 | 0001193125-14-020967 |
| 2013-12-31 | S-1Registration filed | 333-193154 | 0001193125-13-488614 |
| 2013-04-19 | DRSDraft made public | 377-00159 | 0000950123-13-002382 |